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Protocol
AbstrACt
Introduction Increasingly, assessment of healthcare 
technologies and interventions requires the assessment of 
both costs and utilities. Health state utility values (HSUVs) 
are measured using a range of generic and condition-
specific measures. While reviews have identified that 
generic measures of HSUVs may lack validity in adults with 
conditions that result in physical disability, there is little 
information available on the methods used to obtain HSUVs 
in children and adolescents with disabilities. The objectives 
of this systematic review are to describe the methods 
used to obtain HSUVs, including mode of administration 
and psychometric properties, and provide summary 
statistics for HSUVs among children and adolescents with 
disabilities.
Methods and analysis The following databases will be 
searched from inception for English-language studies of 
any design: PubMed, PsychInfo, Medline, Scopus, CINAHL 
Plus, Econlit and EMBASE databases. Two reviewers 
will independently screen titles, abstracts and full text 
articles for studies reporting HSUVs and/or data on the 
psychometric properties of preference-based measures for 
children and adolescents with disabilities aged up to 19 
years. Two reviewers will independently extract data items 
including descriptors of the study methods and sample, 
instruments used to capture HSUVs, summary statistics 
for HSUVs and items relating to the quality of reporting. 
A descriptive summary of results from included studies 
and summary statistics for HSUVs will be presented. If 
sufficient data is identified, we will pool summary statistics 
for HSUVs according to the method used to obtain the 
HSUV using a random effects model. In addition, we will 
explore the determinants of the HSUVs using a meta-
regression.
Ethics and dissemination Ethical approval will not be 
required as no original data will be collected as part of 
this review. The completed review will be submitted for 
publication in a peer-reviewed journal and presentation at 
conferences.
PrOsPErO registration number CRD42018086574.
bACkgrOund
Economic evaluations are increasingly used 
to inform the evidence base in decisions 
regarding the adoption of healthcare inter-
ventions. A cost-utility analysis (CUA), which 
describes the relationship between costs 
and health benefits (using quality of life), 
is commonly used in the appraisal of inter-
ventions and technologies. The strength of 
the CUA is the fact that costs are compared 
with quality-adjusted life years (QALYs), a 
measure that incorporates both the quantity 
and quality of life. By using QALYs, various 
disparate outcomes can be combined into a 
single composite summary outcome which 
allows broad comparisons across different 
disease areas in the health sector. When 
calculating QALYs, quantity is captured 
using life years while quality is captured 
using health state utility values (HSUVs). 
To enhance the transparency and hence 
reliability of evidence from CUA, it is key 
that the process of collecting data for the 
CUA is robust, transparent and systematic.1 2 
HSUVs are ranked on a scale anchored at 1 
(full health) and 0 (a health state of equiv-
alent value to being dead). HSUVs can be 
elicited using methods such as the Time 
Trade Off (TTO) methods or the Standard 
Gamble. Often generic measures, such as 
the EuroQol five dimensions questionnaire 
strengths and limitations of this study
 ► A strength of this review is that it will include 
studies of children and adolescents with a range of 
disabilities. Where possible results will be presented 
according to disability type.
 ► A limitation of this review is that publications that 
are not peer reviewed such as unpublished theses 
and conference presentations will not be included.
 ► This review will also only include reports written 
in English and therefore could exclude relevant 
information.
 ► It may not be possible to report summary statistics 
for health state utility values (HSUVs) if the methods 
used to obtain HSUVs are found to be inappropriate 
for use in this population.
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(EQ-5D), are recommended to be used in economic 
evaluations because they allow comparison across 
healthcare interventions and sectors.2 
Disability is ‘a difficulty in functioning at the body, 
person, or societal levels, in one or more life domains, 
as experienced by an individual with a health condi-
tion in interaction with contextual factors’.3 Disability 
refers to the negative aspects of the interaction between 
individuals with a health condition (such as cerebral 
palsy, cardiovascular disease, depression) and personal 
and environmental factors (such as negative attitudes, 
inaccessible transportation and public buildings, and 
limited social supports).4 Although the prevalence of 
disability varies between countries and within coun-
tries, depending on how disability is conceptualised 
and assessed,4 the global prevalence among adults is 
approximately 15.6%.4 Approximately, 5% of children 
aged 0–14 years worldwide experience a moderate 
or severe disability.4 Research into the health needs, 
health outcomes, and effectiveness of interventions, 
particularly rehabilitation interventions, is a priority for 
improving healthcare among people with disabilities.4 
Encompassed in this is the need to evaluate the cost-ef-
fectiveness of healthcare interventions.
Condition-specific measures of quality of life are often 
used when assessing the effectiveness of interventions in 
children and adults with disabilities.5–7 However, tradi-
tionally, generic preference-based measures such as the 
EQ-5D have been employed in CUA analyses and not 
condition-specific measures.2 The validity of applying 
these generic measures, which have been developed in 
the general population, to groups with specific condi-
tions has been debated.8–10
Several reviews have identified that generic measures 
of HSUVs may lack validity in adults with conditions 
resulting in physical disability.10–13 There is a lack of 
information, however, regarding the utility and psycho-
metric properties of measures used to obtain HSUVs 
in children and adolescents with disabilities. Under-
standing how HSUVs are obtained in children and 
adolescents with disabilities and the psychometric 
properties of these measures in this population is 
important for interpreting the findings of CUA of 
health interventions.
ObjECtIvEs
This review will address the following objectives:
1. Describe the methods used to obtain HSUVs from 
children and adolescents with disabilities.
2. Describe how these methods are administered to chil-
dren and adolecesnts with disabilities.
3. Describe the psychometric properties of the methods 
used to obtain HSUVs from children and adolescents 
with disabilities.
4. Report summary statistics for HSUVs among children 
and adolescents with disabilities obtained from each 
method identified.
MEthOds
The methods used for this systematic review will be 
in line with available recommendations on reviews of 
HSUVs.14–18 In addition, a scoping review was conducted 
to inform the methods of this review. Reporting of the 
review will adhere to recommendations of the preferred 
reporting items for systematic reviews and meta-analyses 
(PRISMA) statement.19 The protocol will be registered 
with the International Prospective Register of Systematic 
Reviews following peer review.
study eligibility
Study designs
We will include: (1) studies reporting HSUVs among chil-
dren and adolescents with disabilities derived from both 
direct (such as Standard Gamble, TTO, visual analogue 
scale) and indirect methods (such as EuroQol EQ-5D and 
all its variants, Child Health Utility 9D (CHU-9D), Assess-
ment of Quality of Life 6D, Paediatric Asthma Health 
Outcome Measure, Health Utilities Index Mark 2, Quality 
of Well-Being Scale and 16D-questionnaire) and (2) 
studies reporting the utility and/or psychometric proper-
ties of measures used to obtain HSUVs from children and 
adolescents with disabilities.
There will be no restriction on the type of studies to be 
included. Examples of types of studies to be included in 
the review are:
 ► Studies that compare existing or new measures of 
HSUVs.
 ► Studies that validate measures of HSUVs.
 ► Randomised clinical trials that incorporate cost utility 
assessments.
Participants
The review will include studies reporting HSUVs for chil-
dren and adolescents with disabilities aged 0–19 years. 
We will include studies reporting HSUVs for the general 
population if they report HSUVs for children and adoles-
cents with disabilities separately. Studies of children and 
adolescents aged 0–19 years with the following broad 
forms of disabilities will be included: (1) intellectual 
impairment (eg, learning difficulties) or intellectual 
disability, (2) physical impairment (eg, mobility impair-
ment, poliomyelitis), (3) developmental disability (eg, 
autism spectrum disorder or cerebral palsy), (4) sensory 
impairments (eg, visual impairment, speech impair-
ment) and (5) multiple impairment—at least two of the 
above.
Where studies include children, adolescents and adults, 
for example participants aged 5–20 years, or adolescents 
and adults, for example participants aged 15–20 years, we 
will extract data on children and adolescents separately if 
possible. If this is not possible, we will include the study 
in the descriptive analysis but not in the quantitative anal-
ysis. Where studies include adults with disabilities, we will 
interpret the results of these studies in the context of the 
proportion of children and/or adolescents included in 
the study.
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Language
We will include articles reported in the English languages 
only.
Exclusion criteria
We will exclude studies reporting HSUVs in adults with 
disabilities only or in children or adults without disabili-
ties. We will also exclude reviews, commentaries, unpub-
lished theses, conference abstracts and any unobtainable 
texts.
search strategy
A systematic search will be conducted to capture HSUVs 
used in children and adolescents with disabilities. The 
following databases will be searched from inception: 
PubMed, PsychInfo, Medline, Scopus, CINAHL Plus, 
Econlit and EMBASE. We will also search for studies on 
the EQ-5D, Health Utilities Inc, National Health Service 
Economic Evaluation Database and Health Technology 
Assessment websites. Reference lists of key papers will be 
reviewed for additional references.
Search terms
The development of the search terms was informed by a 
scoping review of the literature.20–26 Specific search terms 
include different variants of child and adolescent terms 
(infant, newborn, child and adolescent), health utility 
terms (EQ-5D, TTO, Standard Gamble) and disability. A 
sample search strategy is provided in the online Supple-
mentary appendix 1.
Data management
Literature search results will be managed using Mendeley 
reference management software.
Study selection
Two reviewers will review the titles and abstracts for inclu-
sion. If a study appears to meet the inclusion criteria or 
if there is any doubt regarding the inclusion of the study 
the full text of the article will be retrieved. Full text arti-
cles will be reviewed independently by both reviewers and 
disagreements resolved through discussions with a third 
reviewer. Reasons for exclusions will be documented for 
all full text articles. The PRISMA flow diagram19 will be 
used to summarise the number of articles identified, 
retrieved, screened, assessed, included and excluded as 
well as the reasons for exclusions.
data extraction
Data extraction will be conducted independently by two 
reviewers. Disagreements between the two reviewers will 
be resolved primarily through discussions and where 
necessary a third reviewer will be involved. If HSUVs are 
not available from the study report, we will contact the 
authors. A period of 2 months from the request date will 
be allowed for the author to respond.
Data items
Details of the data extraction items are provided 
in the online Supplementary appendix 2. The data 
extraction form has been piloted by two reviewers 
(LK and JR). Data extraction items include a descrip-
tion of the study methods, sample and results as well as 
items relating to the quality of reporting. As this review 
will identify patient-reported outcome measures used to 
obtain HSUVs in children and adolescents with disabili-
ties, the International Society for Quality of Life Research 
(ISOQOL) minimum standards for patient-reported 
outcome measures27 was used to inform data extraction 
items. These items include information on the reliability, 
validity and burden of the patient-reported outcome 
measure, which will aid identification of suitable outcome 
measures as well as highlight improvements in reporting 
and additional research that are required in the field. 
Further, the Checklist for REporting VAluaTion StudiEs 
(CREATE) checklist28 was consulted when developing 
the data extraction items. As the objectives of this review 
are broad, all items on the CREATE checklist may not 
be applicable to all included studies and therefore the 
checklist as a whole will not be used. Instead, items from 
the CREATE checklist informed the data to be extracted 
such as a description of the attributes of the instrument, 
the sampling method, the response rate and reasons for 
excluding any respondents or observations. The items 
extracted will include:
 ► A description of the study background, aims and 
methods: funding sources, conflicts of interest, state-
ment of ethical approval, aim of study, study design, 
duration of study, duration of participation, study 
setting, method of recruitment, sample size, sampling 
method, number randomised to each group and 
description of intervention and comparator (if study 
is a trial).
 ► A description of the participant (and respondent, 
if different) characteristics: age, sex, race, socioec-
onomic status, diagnosis, type of disability, years in 
present disability, disability severity, other medical 
conditions and years in this condition. As there is not 
a standard method of categorising severity across all 
disability types, the method used to categorise severity 
will be extracted from each article.
 ► A description of the methods used to obtain HSUVs: 
instrument (eg, CHU-9D) or direct elicitation tech-
nique (eg, TTO) used, mode of administration (eg, 
telephone, face-to-face), data source (eg, self-re-
ported or proxy), relationship between partici-
pant and respondent if administered by proxy, time 
points measured and reported and length of time to 
complete the instrument or administer the method to 
elicit HSUVs.
 ► A description of the psychometric properties of the 
instrument in children and adolescents with disabil-
ities: a statement of validity, reliability and respon-
siveness (if longitudinal study); methods used to 
determine psychometric properties and statement of 
differences between participants and target popula-
tion if study is examining psychometric properties of 
the instrument
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 ► A description of the results of the study: response 
rates, reasons for missing data, reasons for exclusion 




A summary of the results from the included studies will 
be presented according to disability type (intellectual 
impairment or disability, physical impairment, devel-
opmental disability, sensory impairments, multiple 
impairments) and instrument used to obtain HSUVs if a 
sufficient number of studies for each type is identified. 
In addition, all identified methods of obtaining HSUVs 
and the relevant attributes of their associated studies will 
be tabulated. We will also report the number of studies 
where data extraction items were not available in order 
to provide an overview of the quality of reporting by study 
authors.
Quantitative analyses
If we identify sufficient data of sufficient quality for a 
meta-analysis, we will pool summary statistics for HSUVs 
according to the method used to obtain the HSUV using a 
random effects model. We will only include data obtained 
using methods that are identified as having adequate 
validity and reliability among children and adolescents 
with disabilities. Heterogeneity between the findings of 
the reviewed studies will be assessed using the I2 statistic. 
In addition, we will explore the determinants of the 
HSUVs, including disability type, using a meta-regression. 
Statistical analyses will be performed using STATA soft-
ware V.14.
Ethics and dissemination
Ethical approval will not be required as no original data 
will be collected as part of this review. If a quantitative 
analysis is conducted, it will rely entirely on data extracted 
from published studies. The completed review will be 
submitted for publication in a peer-reviewed journal and 
presented at conferences.
dIsCussIOn
The principal objectives of the planned systematic review 
are to evaluate how HSUVs are obtained in children and 
adolescents with disabilities, report the psychometric 
properties of measures used to obtain HSUVs among chil-
dren and adolescents with disabilities and if appropriate, 
provide summary statistics for HSUVs in this population. 
We will collate this data to identify areas that require 
further research regarding the measurement of HSUVs 
in children and adolescents with disabilities.
Previous literature suggests that adult-specific 
methods of obtaining HSUVs are used in studies of chil-
dren,20 29 30 even though the utility weights obtained from 
these methods have not been adapted to incorporate the 
possibly different child and adolescent preferences.29 30 
These issues may be compounded by potential prob-
lems with administering generic measures to people 
with disabilities10–13 resulting in inaccurate CUA among 
children and adolescents with disabilities and poorly 
informed decisions regarding the adoption of new inter-
ventions in this population.
The intended audience of this review therefore goes 
beyond health economists to guideline developers, poli-
cymakers, clinicians and researchers. In summarising the 
instruments that have been validated for use in this popu-
lation group, we will also highlight those that have not yet 
been validated. We hope that the identification of these 
knowledge gaps will encourage and direct future instru-
ments validation work.
While it is anticipated that this review will provide 
useful information on measures used to obtain HSUVs 
in children and adolescents with disabilities, there are a 
number of limitations with the proposed review. First, as 
reports that are not peer reviewed and are not written in 
English will be excluded from the review, relevant infor-
mation may not be included. This may also reduce the 
generalisability of the findings to specific populations of 
children and adolescents. Further, it may not be possible 
to report summary statistics for HSUVs if the methods 
used to obtain HSUVs are found not to have adequate 
validity and reliability among children and adolescents 
with disabilities. It may also not be possible to determine 
if disability type predicts HSUVs if insufficient data for 
each disability type is identified.
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